Pediatric Oncology in Istanbul
Istanbul JCI-accredited centers offer specialized pediatric oncology for patients aged 0-18, with child-centered multidisciplinary teams including pediatric oncologists, play therapists, child psychologists, and family support specialists.
Most Common Pediatric Cancers
- Leukemia (ALL, AML): Most common childhood cancer. ALL 5-year survival 90%+ with modern protocols (BFM, AIEOP). Minimal residual disease monitoring
- Brain tumors: Medulloblastoma, ependymoma, glioma. Surgery + craniospinal IMRT (if >3 years) + chemotherapy
- Lymphoma: Hodgkin and non-Hodgkin. ABVD or BV-AVD for Hodgkin. 5-year survival 85%+
- Wilms tumor: 90%+ cure rate with surgery + chemotherapy ยฑ radiotherapy
- Neuroblastoma: High-risk: induction + surgery + HDC/ASCT + isotretinoin + dinutuximab
- Bone tumors: Osteosarcoma (MAP), Ewing sarcoma (EURO-EWING)
TURKEY PEDIATRIC SURVIVAL
Turkey pediatric cancer 5-year overall survival: 74.4% (2018-2022 data). Istanbul tertiary centers exceed national average significantly with international protocol adherence.
Cost
Pediatric leukemia treatment in Istanbul: $15,000-40,000 vs $150,000-400,000+ USA. Brain tumor surgery + radiotherapy: $12,000-30,000 vs $80,000-200,000 USA.